- Home
- DTSS vs IPA Comparison
DTSS vs IPA Comparison
Compare DTSS & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- IPA
- Stock Information
- Founded
- DTSS 2014
- IPA 1983
- Country
- DTSS China
- IPA Canada
- Employees
- DTSS N/A
- IPA N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- DTSS Technology
- IPA Health Care
- Exchange
- DTSS Nasdaq
- IPA Nasdaq
- Market Cap
- DTSS 17.6M
- IPA 18.9M
- IPO Year
- DTSS N/A
- IPA 2017
- Fundamental
- Price
- DTSS $2.40
- IPA $0.44
- Analyst Decision
- DTSS
- IPA Strong Buy
- Analyst Count
- DTSS 0
- IPA 2
- Target Price
- DTSS N/A
- IPA $6.00
- AVG Volume (30 Days)
- DTSS 124.3K
- IPA 1.1M
- Earning Date
- DTSS 11-13-2024
- IPA 12-12-2024
- Dividend Yield
- DTSS N/A
- IPA N/A
- EPS Growth
- DTSS N/A
- IPA N/A
- EPS
- DTSS N/A
- IPA N/A
- Revenue
- DTSS $38,176,218.00
- IPA $17,441,886.00
- Revenue This Year
- DTSS N/A
- IPA $4.33
- Revenue Next Year
- DTSS N/A
- IPA $35.64
- P/E Ratio
- DTSS N/A
- IPA N/A
- Revenue Growth
- DTSS 174.14
- IPA 11.21
- 52 Week Low
- DTSS $1.42
- IPA $0.35
- 52 Week High
- DTSS $20.29
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- DTSS 49.53
- IPA 40.98
- Support Level
- DTSS $2.30
- IPA $0.40
- Resistance Level
- DTSS $3.00
- IPA $0.53
- Average True Range (ATR)
- DTSS 0.21
- IPA 0.07
- MACD
- DTSS -0.01
- IPA 0.00
- Stochastic Oscillator
- DTSS 18.92
- IPA 37.76
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.